Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00168467
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2005-09-09
Brief Title:
The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
Sponsor:
Baker Heart Research Institute
Organization:
Baker Heart Research Institute
Study Overview
Official Title:
The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
One important clinical challenge in older individuals is maintaining mobility in the absence of pain Peripheral arterial disease affects up to 12 of adults over 50 and impairs quality of life due to intermittent claudication causing pain and limiting mobility
Conventional therapies have only modest effect in improving symptoms The investigators hypothesise that angiotensin converting enzyme inhibition with ramipril which causes arterial vasodilation also improves clinical symptoms in patients with peripheral arterial disease
Conventional therapies have only modest effect in improving symptoms The investigators hypothesise that angiotensin converting enzyme inhibition with ramipril which causes arterial vasodilation also improves clinical symptoms in patients with peripheral arterial disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None